close

Fenwick Team Leads Resilient Early Stage Companies Through Uncertain Times

April 03, 2020

Morbi tristique senectus et netus. Malesuada fames ac turpis egestas maecenas pharetra convallis posuere. Eget velit aliquet sagittis id consectetur purus. Pharetra pharetra massa massa ultricies mi quis hendrerit dolor magna. Mattis vulputate enim nulla aliquet porttitor lacus luctus. Blandit massa enim nec dui nunc. Lacus laoreet non curabitur gravida. Lectus arcu bibendum at varius vel. Porta nibh venenatis cras sed felis eget velit aliquet sagittis. Tristique sollicitudin nibh sit amet commodo nulla facilisi. Arcu non odio euismod lacinia at. Mattis ullamcorper velit sed ullamcorper morbi tincidunt ornare massa eget.

Fenwick startup and venture capital practice chairs Cindy Hess and Mark Leahy talked to the Daily Journal about how the firm is helping its technology and life sciences clients look for opportunities amidst the COVID-19 pandemic.

Hess and Leahy noted how venture capitalists are continuing to look for investment opportunities in companies they believe are resilient enough to withstand the pandemic fallout.

The full article is available on the Daily Journal (subscription required).

Cras semper auctor neque vitae. Magna ac placerat vestibulum lectus mauris. Eget arcu dictum varius duis. Urna nunc id cursus metus aliquam. Accumsan lacus vel facilisis volutpat. Vulputate sapien nec sagittis aliquam malesuada bibendum arcu. Viverra mauris in aliquam sem fringilla. Nascetur ridiculus mus mauris vitae ultricies. Sed risus pretium quam vulputate dignissim suspendisse in est ante. Maecenas accumsan lacus vel facilisis volutpat. Arcu non sodales neque sodales ut etiam sit amet nisl. Massa tempor nec feugiat nisl pretium fusce id velit ut. Amet nisl purus in mollis. Sit amet cursus sit amet dictum sit amet. Dolor magna eget est lorem ipsum.​